P366 The efficacy of vedolizumab for induction of clinical response and remission in anti-TNF naïve patients with inflammatory bowel disease – a multicenter European real world experience

Authors :: Dimitrios K. Christodoulou
K.H. Katsanos
Yulia Ron
G. Fiorino
Taina Sipponen
Daniela Pugliese
Daniel C. Baumgart
P.R. Steinhagen
Bella Ungar
A Bar-Gil Shitrit
Xavier Roblin
Uri Kopylov
A. Armuzzi
Iris Dotan
Shomron Ben-Horin
Mariangela Allocca
Rami Eliakim
Shaji Sebastian
Source :: Journal of Crohn's and Colitis. 11:S264-S265
Publication Year :: 2017
Publisher :: Oxford University Press (OUP), 2017.

Subjects :: medicine.medical_specialty
business.industry
Gastroenterology
General Medicine
medicine.disease
Inflammatory bowel disease
Vedolizumab
Surgery
Therapy naive
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
030211 gastroenterology & hepatology
Tumor necrosis factor alpha
business
medicine.drug

Tools